210 related articles for article (PubMed ID: 27025651)
61. The novel fish miRNA, Soc-miR-118, functions as a negative regulator in NF-κB-mediated inflammation by targeting IL-6 in teleost fish.
Yu J; Chu Q; Zhou J; Zhang L
Int J Biol Macromol; 2024 Jun; 269(Pt 1):132100. PubMed ID: 38710252
[TBL] [Abstract][Full Text] [Related]
62. Frontline Science: Targeted expression of a dominant-negative high mobility group A1 transgene improves outcome in sepsis.
Baron RM; Kwon MY; Castano AP; Ghanta S; Riascos-Bernal DF; Lopez-Guzman S; Macias AA; Ith B; Schissel SL; Lederer JA; Reeves R; Yet SF; Layne MD; Liu X; Perrella MA
J Leukoc Biol; 2018 Oct; 104(4):677-689. PubMed ID: 29975792
[TBL] [Abstract][Full Text] [Related]
63. The role of high mobility group AT-hook 1 in viral infections: Implications for cancer pathogenesis.
Akade E; Jalilian S
Int J Biochem Cell Biol; 2024 Apr; 169():106532. PubMed ID: 38278412
[TBL] [Abstract][Full Text] [Related]
64. CARD10 cleavage by MALT1 restricts lung carcinoma growth in vivo.
Israël L; Glück A; Berger M; Coral M; Ceci M; Unterreiner A; Rubert J; Bardet M; Ginster S; Golding-Ochsenbein AM; Martin K; Hoyler T; Calzascia T; Wieczorek G; Hillenbrand R; Ferretti S; Ferrero E; Bornancin F
Oncogenesis; 2021 Apr; 10(4):32. PubMed ID: 33824280
[TBL] [Abstract][Full Text] [Related]
65. Selective MALT1 paracaspase inhibition does not block TNF-α production downstream of TLR4 in myeloid cells.
Unterreiner A; Stoehr N; Huppertz C; Calzascia T; Farady CJ; Bornancin F
Immunol Lett; 2017 Dec; 192():48-51. PubMed ID: 29079202
[No Abstract] [Full Text] [Related]
66. The HMGA1 Pseudogene 7 Induces miR-483 and miR-675 Upregulation by Activating Egr1 through a ceRNA Mechanism.
De Martino M; Palma G; Azzariti A; Arra C; Fusco A; Esposito F
Genes (Basel); 2017 Nov; 8(11):. PubMed ID: 29149041
[TBL] [Abstract][Full Text] [Related]
67. CARD14 Signalling Ensures Cell Survival and Cancer Associated Gene Expression in Prostate Cancer Cells.
Vanneste D; Staal J; Haegman M; Driege Y; Carels M; Van Nuffel E; De Bleser P; Saeys Y; Beyaert R; Afonina IS
Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009554
[TBL] [Abstract][Full Text] [Related]
68. Slowing Down Aging.
Meyer K; Yankner BA
Cell Metab; 2017 Oct; 26(4):592-593. PubMed ID: 28978424
[TBL] [Abstract][Full Text] [Related]
69. Signalling in gene silencing.
Wassenegger M; Pélissier T
Trends Plant Sci; 1999 Jun; 4(6):207-209. PubMed ID: 10366874
[No Abstract] [Full Text] [Related]
70. Neutrophil-specific deletion of the CARD9 gene expression regulator suppresses autoantibody-induced inflammation in vivo.
Németh T; Futosi K; Sitaru C; Ruland J; Mócsai A
Nat Commun; 2016 Apr; 7():11004. PubMed ID: 27032818
[TBL] [Abstract][Full Text] [Related]
71. Alternative splicing of MALT1 controls signalling and activation of CD4(+) T cells.
Meininger I; Griesbach RA; Hu D; Gehring T; Seeholzer T; Bertossi A; Kranich J; Oeckinghaus A; Eitelhuber AC; Greczmiel U; Gewies A; Schmidt-Supprian M; Ruland J; Brocker T; Heissmeyer V; Heyd F; Krappmann D
Nat Commun; 2016 Apr; 7():11292. PubMed ID: 27068814
[TBL] [Abstract][Full Text] [Related]
72. Psoriasis mutations disrupt CARD14 autoinhibition promoting BCL10-MALT1-dependent NF-κB activation.
Howes A; O'Sullivan PA; Breyer F; Ghose A; Cao L; Krappmann D; Bowcock AM; Ley SC
Biochem J; 2016 Jun; 473(12):1759-68. PubMed ID: 27071417
[TBL] [Abstract][Full Text] [Related]
73. MALT1 inhibitors prevent the development of DSS-induced experimental colitis in mice via inhibiting NF-κB and NLRP3 inflammasome activation.
Liu W; Guo W; Hang N; Yang Y; Wu X; Shen Y; Cao J; Sun Y; Xu Q
Oncotarget; 2016 May; 7(21):30536-49. PubMed ID: 27105502
[TBL] [Abstract][Full Text] [Related]
74. Development of new Malt1 inhibitors and probes.
Xin BT; Schimmack G; Du Y; Florea BI; van der Marel GA; Driessen C; Krappmann D; Overkleeft HS
Bioorg Med Chem; 2016 Aug; 24(15):3312-29. PubMed ID: 27085674
[TBL] [Abstract][Full Text] [Related]
75. Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma.
Yang Y; Kelly P; Shaffer AL; Schmitz R; Yoo HM; Liu X; Huang DW; Webster D; Young RM; Nakagawa M; Ceribelli M; Wright GW; Yang Y; Zhao H; Yu X; Xu W; Chan WC; Jaffe ES; Gascoyne RD; Campo E; Rosenwald A; Ott G; Delabie J; Rimsza L; Staudt LM
Cancer Cell; 2016 Apr; 29(4):494-507. PubMed ID: 27070702
[TBL] [Abstract][Full Text] [Related]
76. PM
Liu CW; Lee TL; Chen YC; Liang CJ; Wang SH; Lue JH; Tsai JS; Lee SW; Chen SH; Yang YF; Chuang TY; Chen YL
Part Fibre Toxicol; 2018 Jan; 15(1):4. PubMed ID: 29329563
[TBL] [Abstract][Full Text] [Related]
77. miR-26 family and its target genes in tumorigenesis and development.
Li C; Li Y; Lu Y; Niu Z; Zhao H; Peng Y; Li M
Crit Rev Oncol Hematol; 2021 Jan; 157():103124. PubMed ID: 33254041
[TBL] [Abstract][Full Text] [Related]
78. The effect of HMGA1 in LPS-induced Myocardial Inflammation.
Cai ZL; Shen B; Yuan Y; Liu C; Xie QW; Hu TT; Yao Q; Wu QQ; Tang QZ
Int J Biol Sci; 2020; 16(11):1798-1810. PubMed ID: 32398950
[No Abstract] [Full Text] [Related]
79. miR-26 suppresses adipocyte progenitor differentiation and fat production by targeting
Acharya A; Berry DC; Zhang H; Jiang Y; Jones BT; Hammer RE; Graff JM; Mendell JT
Genes Dev; 2019 Oct; 33(19-20):1367-1380. PubMed ID: 31488578
[TBL] [Abstract][Full Text] [Related]
80. The translational potential of miR-26 in atherosclerosis and development of agents for its target genes ACC1/2, COL1A1, CPT1A, FBP1, DGAT2, and SMAD7.
Chen W; Wu X; Hu J; Liu X; Guo Z; Wu J; Shao Y; Hao M; Zhang S; Hu W; Wang Y; Zhang M; Zhu M; Wang C; Wu Y; Wang J; Xing D
Cardiovasc Diabetol; 2024 Jan; 23(1):21. PubMed ID: 38195542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
